A comparison of the diagnostic value of MRI and 18F-FDG-PET/CT in suspected spondylodiscitis. by Smids, C et al.
1 3
DOI 10.1007/s15010-016-0914-y
Infection
ORIGINAL PAPER
A comparison of the diagnostic value of MRI and 18F‑FDG‑PET/
CT in suspected spondylodiscitis
Carolijn Smids1 · Ilse J. E. Kouijzer1 · Fidel J. Vos1,2 · Tom Sprong3 · 
Allard J. F. Hosman4 · Jacky W. J. de Rooy5 · Erik H. J. G. Aarntzen5 · 
Lioe‑Fee de Geus‑Oei5,6,7 · Wim J. G. Oyen5 · Chantal P. Bleeker‑Rovers1 
Received: 21 March 2016 / Accepted: 3 June 2016 
© The Author(s) 2016. This article is published with open access at Springerlink.com
performed within a 2-week time span. Imaging results were 
compared to the final clinical diagnosis and follow-up data 
were collected.
Results Sixty-eight patients were included of whom 
49 patients were diagnosed with spondylodiscitis. MRI 
showed an overall sensitivity of 67 % and specificity of 
84 %. Diagnostic accuracy was 58 %, when MRI was per-
formed within 2 weeks after the start of symptoms and 
improved to 82 %, when performed more than 2 weeks 
after onset of symptoms. 18F-FDG-PET/CT showed a sen-
sitivity of 96 % and a specificity of 95 %, with no relation 
to the interval between the scan and the start of symptoms.
Conclusions As compared to MRI, 18F-FDG-PET/CT has 
superior diagnostic value for detecting early spondylodisci-
tis. After 2 weeks both techniques perform similarly.
Keywords Spondylodiscitis · MRI · 18F-FDG-PET/CT · 
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Introduction
The prevalence of spondylodiscitis, a severe infection of 
the spine, is increasing in our ageing society [1]. The enti-
ties spondylodiscitis, discitis, and vertebral osteomyelitis 
refer to the exact anatomic localization of the infection, 
but since diagnosis and management are usually identical, 
spondylodiscitis will be used in this article when refer-
ring to these types of infections. Common complications, 
which may result in paraplegia and other neurological dam-
age, are epidural and spinal abscesses, and paravertebral 
or psoas abscesses. One-third of the patients suffer from 
residual spinal dysfunction or persistent pain after recovery 
[2, 3]. Thus, early and accurate detection is crucial for suc-
cessful management and improved neurological outcome.
Abstract 
Purpose The purpose of this study was to evaluate the 
diagnostic value of 18F-fluorodeoxyglucose (FDG) positron 
emission tomography and computed tomography (PET/CT 
scan) and magnetic resonance imaging (MRI) in diagnos-
ing spondylodiscitis and its complications, such as epidural 
and paraspinal abscesses.
Methods From January 2006 to August 2013 patients with 
a clinical suspicion of spondylodiscitis, with an infec-
tion, or with fever of unknown origin were retrospectively 
included if 18F-FDG-PET/CT and MRI of the spine were 
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The diagnosis of spondylodiscitis is based on clinical, 
laboratory, and radiological features. Symptoms and signs 
of spondylodiscitis are often non-specific, so diagnosing 
spondylodiscitis is difficult in many patients. Spondylodis-
citis is commonly diagnosed in patients with complicated 
bacteraemia [4]. Contrast-enhanced magnetic resonance 
imaging (CE-MRI) is the modality of choice in current 
clinical practice. Small studies investigating the value of 
magnetic resonance imaging (MRI) in diagnosing spondy-
lodiscitis showed a sensitivity of 82–96 %, specificity of 
85–93 %, and accuracy of 81–94 % [5–7].
Combined 18F-fluorodeoxyglucose (FDG) positron 
emission tomography and computed tomography (PET/CT) 
is increasingly used in the diagnostic workup of infectious 
diseases. Since 18F-FDG-PET/CT has been shown to be 
cost-effective in patients with Gram-positive bacteraemia 
[8], many of the patients suspected of spondylodiscitis after 
bacteraemia undergo 18F-FDG-PET/CT. No large studies 
comparing the diagnostic value of 18F-FDG-PET/CT and 
MRI in patients with a suspicion of spondylodiscitis have 
been performed. Small studies speculated that 18F-FDG-
PET might have a higher sensitivity (up to 100 %) than 
MRI in diagnosing spondylodiscitis, especially in the early 
stages of disease [6, 9, 10]. This might be explained by the 
different features of both imaging modalities; MRI merely 
relies on anatomical changes, whereas 18F-FDG-PET visu-
alizes glucose metabolism, which is already increased in 
the very early stages of inflammation. PET/MRI systems 
have been technically developed ahead of considering and 
identifying clinical applications. So, it is of importance to 
find indications where PET/MRI in a one-stop shop could 
benefit and where the unique features of combined PET/
MRI have potential competitive advantages over PET/CT. 
Since there are only a limited number of studies available 
on this topic, the purpose of this study was to determine the 
diagnostic value of MRI and 18F-FDG-PET/CT in diagnos-
ing spondylodiscitis and in diagnosing its complications, 
such as epidural, spinal, paravertebral, and psoas abscesses 
in a setting of clinical practice.
Materials and methods
Study design
Patients with a clinical suspicion of spondylodiscitis, sys-
temic infection, or with fever of unknown origin in whom 
18F-FDG-PET/CT was performed between January 2006 
and August 2013 were identified using the electronic data-
base of the Department of Radiology and Nuclear Medi-
cine. Patients were included if MRI of the spine was per-
formed within 2 weeks before or after 18F-FDG-PET/CT. 
Exclusion criteria were MRI or 18F-FDG-PET/CT done 
within 6 weeks after spinal surgery or known spinal frac-
ture, or no established final clinical diagnosis. Patients from 
three hospitals were included: Radboud university medi-
cal center (Radboudumc), a tertiary referral center, Cani-
sius-Wilhelmina Hospital, a community hospital, and Sint 
Maartenskliniek, a hospital specializing in musculoskeletal 
related disorders, all located in Nijmegen, The Netherlands.
The final clinical diagnosis served as standard of refer-
ence. Spondylodiscitis was considered to be the final clini-
cal diagnosis in patients in whom a microorganism was 
isolated through biopsy, surgery, or from blood cultures in 
combination with compatible clinical and laboratory find-
ings and/or imaging follow-up showing response to anti-
biotic therapy. According to the Dutch law, this study was 
exempt from approval by an ethics committee, because of 
the retrospective character of this study and the anonymous 
storage of data.
Diagnostic workup
An integrated PET/CT scanner (Biograph or mCT; Sie-
mens for Radboudumc and Sint Maartenskliniek, Philips 
TOF for Canisius-Wilhelmina Hospital) was used for 
obtaining data. Before 18F-FDG injection patients fasted 
and any glucose or insulin-containing infusions were dis-
continued for at least 6 h. At the time of 18F-FDG injec-
tion glucose was below 12 mmol/l in all patients, including 
diabetic patients. 1 h after intravenous injection of mean 
200 MBq of 18F-FDG (Covidien, Petten, The Netherlands 
or IBA, Amsterdam, The Netherlands), a low-dose CT scan 
of the area between proximal femora and base of the skull 
was acquired for anatomic correlation and attenuation cor-
rection of the PET data. Emission images of the same area 
were acquired. Spinal infection on 18F-FDG-PET/CT was 
defined as increased 18F-FDG of the spine compared to 
uptake in bone marrow, or when 18F-FDG was increased in 
soft tissues around the spine. MRI with (55/68) or without 
(13/68) intravenous injection of gadolinium was performed 
on a 1.5 T Avanto MRI system; Siemens Erlangen, Ger-
many in case of Radboudumc and Philips Intera 1.5 T in 
case of Sint Maartenskliniek, and Philips Achieva 1.5 T in 
case of Canisius-Wilhelmina Hospital. Spinal infection on 
MRI was defined as an affected intravertebral disc, or in 
case of narrowing of the intravertebral disc, or in case of 
present increased contrast in the spine. Because the purpose 
of this study was to investigate the value of 18F-FDG-PET/
CT and MRI in spondylodiscitis in the daily clinical set-
ting, the original clinical reports of 18F-FDG-PET/CT and 
MRI were used for this study. For this reason, no reread-
ing by independent radiologists and nuclear physicians was 
performed.
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Patient follow‑up
Follow-up data of patients at 3 and 6 months after presen-
tation, as well as from the last available follow-up, were 
collected from medical charts. Results of diagnostic tests 
(blood cultures, other cultures, biopsies, C-reactive pro-
tein (CRP)) and treatment (surgery/antibiotic therapy) 
were obtained. Outcome was classified as recovery, still on 
treatment of the first episode of spondylodiscitis, relapse, 
neurological impairment, persistent back pain, or death 
(overall and infection-related). Relapse was defined as a 
second episode of spondylodiscitis with the same causa-
tive organism after completion of adequate antibiotic treat-
ment of at least 6 weeks duration. Neurological impairment 
was defined as irreversible spinal cord injury, when avail-
able, classified according to the American Spinal Injury 
Association Impairment Scale, with motor weakness or 
sensory loss existing at last follow-up. Mortality at day 30 
and overall was calculated. Mortality was considered to be 
infection-related when a patient died during the episode of 
spondylodiscitis with persistent signs or symptoms of sys-
temic infection or after relapse.
Statistical analysis
All data were collected in a structured database using SPSS 
statistics (version 20.0; IMB Corp.). Sensitivity, specificity, 
positive predictive value (PPV), negative predictive value 
(NPV), and accuracy were calculated with 95 % confidence 
intervals (CIs). Differences in outcomes were tested using 
Fisher’s exact test for categorical variables. Differences in 
continuous variables were tested with Mann–Whitney U 
test. Statistical significance was defined as a p value less 
than 0.05.
Results
Clinical features and diagnosis
Between January 2006 and August 2013, 75 eligible 
patients were identified. Three patients were excluded 
because MRI or 18F-FDG-PET/CT was done within 
6 weeks after spinal surgery. Four patients were excluded 
because no final clinical diagnosis was established. Sixty-
three patients were recruited from the Radboudumc and 
five from the other two hospitals. Baseline characteristics 
of the 68 study patients are provided in Table 1. Forty-
nine patients (72 %) were diagnosed with spondylodis-
citis. Fever (≥38 °C), back pain, elevated CRP, and posi-
tive blood cultures occurred significantly more often in the 
patients diagnosed with spondylodiscitis (Tables 1, 2).
Of all 49 patients with a clinical diagnosis of spondylo-
discitis, a causative organism was identified in 46 patients. 
The most prevalent pathogens were Staphylococcus aureus 
(n = 25) and Streptococcus species (n = 11) (Table 2). The 
different ways the final clinical diagnoses of spondylodis-
citis were established are shown in Table 3. Patients even-
tually not diagnosed with spondylodiscitis had degenera-
tive spinal changes (n = 7), spinal disc herniation (n = 2), 
cauda equina syndrome (n = 1), metastatic neoplasm 
(n = 1), S. aureus meningitis (n = 1), spinal hemangioma 
(n = 1), osteomyelitis of the pelvis (n = 1), or back pain of 
unknown origin (n = 5).
MRI
The overall sensitivity of diagnosing spondylodiscitis 
with MRI was 67 % with a specificity of 84 %, a PPV 
of 92 %, an NPV of 50 %, and a diagnostic accuracy of 
72 %. Eleven of 16 false-negative MRIs were performed 
within 2 weeks of onset of symptoms (fever or back pain). 
In eight of these 16 patients, MRI was repeated, median 
41 days after onset of symptoms (range 15–60) and median 
22.5 days (range 9–46) after the first MRI. In one patient, 
this second MRI was of insufficient quality due to move-
ment artifacts caused by claustrophobia. In the remaining 7 
patients, the second MRI confirmed spondylodiscitis. The 
accuracy of MRI performed within 2 weeks after emerging 
of symptoms was 58 % compared to an accuracy of 82 % 
when MRI was performed more than 2 weeks after onset of 
symptoms (Table 4). In case of a prior probability of 50 % 
for spondylodiscitis, PPV was 82 % and NPV was 72.5 % 
for MRI. In case of a 30 % prior probability, the PPV is 
62 % and the NPV is 83 % for MRI.
In 13 patients (19 %), MRI was performed without intra-
venous contrast for various reasons including presumed 
allergy. Three (23 %) of the MRIs without contrast were 
false negative compared to 13 (24 %) of the contrast-
enhanced MRIs.
18F‑FDG‑PET/CT
The overall sensitivity for diagnosing spondylodiscitis with 
18F-FDG-PET/CT was 96 % with a specificity of 95 %, 
a PPV of 98 %, a NPV of 90 %, and an overall diagnostic 
accuracy of 96 %. Diagnostic value did not differ signifi-
cantly when comparing imaging within or after 2 weeks from 
onset of symptoms (Table 4). In case of a prior probability 
of 50 % for spondylodiscitis, PPV was 94 % and NPV was 
94 % for 18F-FDG-PET/CT. In case of a 30 % prior prob-
ability, the PPV is 90.5 % and the NPV is 98 % for PET/CT.
In a patient with a history of esophageal carcinoma, now 
presenting with fever and back pain, 18F-FDG-PET/CT 
C. Smids et al.
1 3
showed increased metabolism at the lumbosacral region of 
the spine, directing to a differential diagnosis of spondylo-
discitis or metastasis. CE-MRI showed a lesion of S1 and 
S2 with soft tissue spread into the spinal canal and around 
the root of S1 on the left, suspect for a metastatic neoplasm. 
The final clinical diagnosis was based on open-biopsy 
results, showing squamous cell carcinoma. 18F-FDG-PET/
CT was scored as false positive for infection. The only two 
patients with false-negative results of 18F-FDG-PET/CT 
also had a false-negative CE-MRI. A second CE-MRI and 
a second PET/CT performed more than 2 weeks after the 
onset of symptoms, however, confirmed spondylodiscitis.
Epidural or spinal abscesses were found in 15 patients 
(31 %) with a sensitivity for MRI of 93 and 47 % for 
18F-FDG-PET/CT (Table 5; Fig. 1). 18F-FDG-PET/CT, on 
the other hand, showed higher sensitivity than MRI in diag-
nosing paravertebral abscesses (94 and 61 %, respectively), 
and psoas abscesses (100 and 63 %, respectively).
Treatment and outcome
All patients with spondylodiscitis received antibiotic 
treatment. Median duration of antibiotic treatment was 
124 days, with a median of 46 days of intravenous therapy 
followed by oral administration of median 79 days (Fig. 2). 
Five patients (10 %) underwent spinal surgery after the 
diagnosis of spondylodiscitis, because they developed 
progressive neurological impairment due to spinal cord 
compression.
The median duration of follow-up was 401 days (range 
76–2340 days). At the last follow-up, six out of all 49 
patients with spondylodiscitis showed neurological impair-
ment (13 %), two patients experienced an episode of 
relapse (4 %), and eight patients died (17 %). Two patients 
died of an infection-related cause (4 % of all patients with 
spondylodiscitis): one during the first episode of spondylo-
discitis (40 days after presentation) and one patient 4 days 
after admission due to relapsing spondylodiscitis with the 
same causative organism (S. aureus), 8 months after the 
end of the first period of treatment of spondylodiscitis. One 
patient with terminal heart failure died from a respiratory 
tract infection, 29 months after the end of adequate treat-
ment of spondylodiscitis. Another patient died of recurrent 
bacteraemia with different microorganisms, due to bowel 
failure and chronic graft-versus-host disease, 19 months 
after the end of adequate treatment of spondylodiscitis. In 
Table 1  Baseline characteristics
a One patient died during admission, 40 days after presentation
b Of all 49 patients, 21 had more than one affected spinal level
Final clinical diagnosis of  
spondylodiscitis
Final clinical diagnosis other  
than spondylodiscitis
p value
Total number of patients 49 (72 %) 19 (28 %) –
Male 24 (49 %) 11 (58 %) 0.594
Median age (years) 64 (10–88) 65 (20–78) 0.795
Hospital admission 49 (100 %) 15 (79 %)
 Median duration of hospital admission in days (range) 46 (10–126)a 19 (7–67) 0.004
Fever (≥38 °C) 46 (94 %) 10 (53 %) <0.001
 Median duration of fever in days (range) 11.5 (1–136) 18 (5–60) 0.048
Back pain 47 (96 %) 12 (63 %) 0.001
CRP (mg/l)
 Median CRP at presentation (range) 188 (9–518) 64 (<5–396) 0.007
 Median maximal CRP (range) 242 (9–518) 141 (<5–396) 0.004
Malignancy 9 (18 %) 5 (26 %) 0.512
Immunocompromised 9 (18 %) 6 (31 %) 0.329
Osteosynthesis material spine 1 (2 %) 1 (5 %) 0.484
Spinal surgery >6 weeks before imaging 5 (10 %) 2 (11 %) 1.000
Time between surgery and imaging in months 2, 41, 67, 468, 510 6, 297 –
Spine levelb
 Cervical 14 – –
 Thoracic 18 – –
 Lumbar 31 – –
 Sacral 8 – –
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four patients the cause of death could not be ascertained. 
They died 9, 10, 22, and 27 months after the end of ade-
quate treatment of spondylodiscitis, without signs of persis-
tent infection or relapse of spondylodiscitis.
Discussion
In this study we retrospectively evaluated the diagnostic 
value of 18F-FDG-PET/CT and MRI in diagnosing spondy-
lodiscitis and its complications in a cohort of 68 patients. 
Our study showed a significantly better overall sensitivity, 
NPV, and accuracy of 18F-FDG-PET/CT for diagnosing 
spondylodiscitis when compared to MRI, especially when 
imaging was performed within the first 2 weeks after onset 
of symptoms. Previous studies showing a higher diagnos-
tic value of MRI might be based on findings of late MRI, 
but time from the start of symptoms until performance of 
MR imaging was not reported in these studies [5–7]. Modic 
et al. described 37 patients with suspected spondylodiscitis, 
of which 23 received a final diagnosis of spondylodiscitis 
[5]. In 14 patients this diagnosis was confirmed through 
biopsy results, but in nine patients the diagnosis was solely 
based on blood cultures or clinical evaluation. In this study, 
however, MRI was performed without the use of contrast 
agents. Early abnormalities, such as bone marrow edema 
are usually atypical [11]. Particularly in this type of infec-
tions, gadolinium enhancement could improve accuracy of 
MRI, due to increased vascularization [12, 13]. Neverthe-
less, the use of MRI as modality of choice is mainly based 
on the results of the study of Modic et al. [5]. In our study, 
early MRI was false negative in 11 patients despite gado-
linium contrast in 9 patients. Despite the fact that CE-MRI 
was not performed in all patients, diagnostic outcomes of 
MRI showed no significant difference when comparing 
patients with and without contrast enhancement. Dunbar 
et al. described four cases of clinically suspected spondy-
lodiscitis with early CE-MR imaging showing atypical 
abnormalities that were attributed to degenerative changes 
[14], as was the case in our study. Repeated CE-MRI 8 to 
22 days later confirmed spondylodiscitis in all four cases. 
Table 2  Microbiological findings
a S. aureus (n = 3), E. coli (n = 1) and polymicrobial (n = 1, S. aureus and Streptococcus milleri)
b E. coli and coagulase-negative Staphylococcus, S. aureus and beta-hemolytic group C Streptococcus
c Peptostreptococcus micros, Enterobacter cloacae and Enterococcus faecium
Final clinical diagnosis  
of spondylodiscitis
Final clinical diagnosis other  
than spondylodiscitis
p value
Blood cultures
 Positive 45 (92 %) 5 (26 %)a <0.001
 Median number of blood cultures taken (range) 11 (2–46) 6 (0–29) 0.001
 Median duration of positive blood cultures in days (range) 4 (1–71) 3 (1–10) 0.832
Tissue cultures (biopsy) 12 – –
 Positive 5 (42 %) – –
Causative organism 46 (94 %) – –
 Staphylococcus aureus 25 (51 %) – –
 Coagulase-negative staphylococcus 2 (4 %) – –
 Streptococcus species 11 (22 %) – –
 Escherichia coli 2 (4 %) – –
 Candida albicans 1 (2 %) – –
 Polymicrobial infection 2 (4 %)b – –
 Miscellaneous 3 (6 %)c – –
No causative organism 3 (6 %) – –
Table 3  Establishing the final clinical diagnosis of spondylodiscitis
a In combination with imaging results showing spondylodiscitis
Final clinical diagnosis of spondylodiscitis 49
Positive cultures of spinal biopsy 5
 CT-guided 1
 Open 4
Vertebral biopsies showing osteomyelitis 2
Blood cultures and cultures from abscesses near the spinal level 
of infection positive for the same micro-organisma
4
Blood cultures and cultures from the cerebrospinal fluid positive 
for the same micro-organisma
2
Positive blood culturesa 33
Clinical symptoms in combination with imaging results and 
resolution of symptoms after treatment
3
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In line with our data, Carragee et al. showed in a group of 
103 patients with spondylodiscitis that sensitivity of MRI 
was 55 % when imaging was performed within 2 weeks 
after onset of symptoms compared to 76 % after 2 weeks 
of symptoms [15]. In this study it was not reported whether 
contrast was used or not.
Three prospective studies (using stand-alone PET, not 
integrated PET/CT) have suggested superiority, or at least 
equivalent results, of 18F-FDG-PET over MRI in diagnos-
ing spondylodiscitis, but could not find significant differ-
ences between these imaging modalities, as they included 
only small numbers of patients [6, 9, 10]. Schmitz et al. 
showed a sensitivity of 18F-FDG-PET of 100 % in 16 
patients suspected of spondylodiscitis in whom the final 
diagnosis was based on histopathology (n = 12) [9]. MRI 
was performed in 15 patients and showed equivalent 
diagnostic value when compared to 18F-FDG-PET. In 16 
patients suspected of spondylodiscitis, Gratz et al. showed 
a sensitivity of 100 % and a specificity of 87 % in diagnos-
ing spondylodiscitis with 18F-FDG-PET, with high reliabil-
ity in both low and high grade infection [6]. In this study, 
MRI showed a sensitivity of 82 % and a specificity of 
85 %, with most false-negative results in patients with low-
grade spondylodiscitis [6]. In one patient, 18F-FDG-PET 
showed an extensive paravertebral abscess, which was not 
Table 4  Diagnostic value of 
MRI and 18F-FDG-PET/CT 
related to the timing of the 
imaging procedure
≤ 14days of start of symptoms >14 days of start of symptoms Total
MRI 29 39 68
  Sensitivity 50 (28.3–71.8) 82 (61.9–93.6) 67 (52.5–80.0)
  Specificity 86 (42.2-97.6) 83 (51.6–97.4) 84 (60.4–96.4)
  PPV 92 (61.5-98.6) 92 (73.0–98.7) 92 (77.5–98.2)
  NPV 35 (14.3-61.7) 67 (38.4–88.1) 50 (31.9–68.1)
  Accuracy 58 (40.0-76.0) 82 (69.9–94.1) 72 (61.3–82.7)
18F-FDG-PET/CT 32 36 68
  Sensitivity 96 (79.6–99.3) 96 (78.8–99.3) 96 (86.0–99.4)
  Specificity 100 (58.9–100) 92 (61.5–98.6) 95 (73.9–99.1)
  PPV 100 (85.6–100) 96 (78.8–99.3) 98 (88.9–99.7)
  NPV 88 (47.4–97.9) 92 (61.5–98.6) 90 (68.3–98.5)
Accuracy 97 (91.1–100) 94 (86.2–100) 96 (91.3–100)
Table 5  Abscesses in patients with spondylodiscitis and sensitivity 
of MRI and 18F-FDG-PET/CT
Specificity was 100 % for all imaging methods, but in most cases no 
other diagnostic procedures were performed to confirm the found 
abscesses in another way
a Patients with abscesses at different locations are accounted for in 
both groups. There were 44 abscesses found in 31 patients
b In two patients a psoas abscess and a lumbar paravertebral abscess 
were missed because only cervical MRI was performed
c One epidural abscess initially missed in both MR imaging and 
18F-FDG-PET/CT
Sensitivity for diagnos-
ing
Totala MRIb 18F-FDG-PET/CTc
Epidural/spinal abscess 15 (31 %) 14 (93 %) 7 (47 %)
Paravertebral abscess 18 (37 %) 11 (61 %) 17 (94 %)
Psoas abscess 8 (16 %) 5 (63 %) 8 (100 %)
Retropharyngeal abscess 3 (6 %) 2 (67 %) 3 (100 %)
Fig. 1  18F-FDG-PET/CT and MRI images of the spine in a 67-year-
old man with Streptococcus viridans bacteraemia. 18F-FDG-PET/CT 
showed increased 18F-FDG-accumulation at the level Th8–Th9, cor-
rectly classified as spondylodiscitis. MRI correctly reported discitis 
with bulging into the spinal canal, suspect for an abscess. The patient 
received prolonged antibiotic treatment
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seen on MRI. Stumpe et al. evaluated the use of 18F-FDG-
PET in differentiating spondylodiscitis and degenerative 
abnormalities in 30 patients as compared to MRI [10]. 
Only four patients had a final diagnosis of spondylodisci-
tis. 18F-FDG-PET showed a sensitivity and specificity of 
100 % in diagnosing spondylodiscitis compared to a sensi-
tivity of 50 % and a specificity of 96 % in MRI. In only 14 
out of 30 patients, a contrast-enhanced MR was performed. 
However, the results of their study implied that 18F-FDG-
PET would be useful in differentiating between spondylo-
discitis and degenerative disease. A more recent study by 
Fuster et al. described the value of integrated 18F-FDG-
PET/CT compared to bone scan and 67Ga (but not MRI) in 
the diagnosis of spondylodiscitis [16]. An accuracy of 88 % 
was found for 18F-FDG-PET/CT, with a sensitivity of 89 % 
and specificity of 88 %. Another recent study of Fuster 
et al. investigated the diagnostic value of 18F-FDG-PET/CT 
and MRI in 26 patients with spondylodiscitis [17]. Sensi-
tivity, specificity, PPV, NPV, and accuracy were 83, 88, 94, 
70, and 84 % for 18F-FDG-PET/CT, and 94, 38, 77, 75, and 
81 % for MRI, respectively. A limitation of this study was 
the low number of patients. In contrast to our study, these 
studies did not evaluate the effect of early and late imaging 
on the diagnostic value of 18F-FDG-PET/CT and MRI. In 
fact, none of the studies reported the time interval between 
start of symptoms and image acquisition.
Recently, a meta-analysis of diagnostic data on the 
value of FDG-PET in spondylodiscitis was performed [18]. 
The authors reported a sensitivity of 97 % and specificity 
of 88 %. However, this study analyzed mainly FDG-PET 
studies (n = 9) rather than FDG-PET/CT studies (n = 3).
MRI is established as the modality of choice in diagnos-
ing epidural abscesses [7, 19], while there are no studies 
on the accuracy of 18F-FDG-PET/CT in epidural abscesses. 
Indeed, in our study, MRI detected nearly all epidural and 
spinal abscesses, while 18F-FDG-PET/CT was negative 
in approximately half of the cases, supporting the cur-
rent diagnostic standards. In diagnosing paravertebral and 
psoas abscesses, however, sensitivity of 18F-FDG-PET/CT 
was higher than that of MRI. Solid conclusions are dif-
ficult to draw, since in three patients the abscesses were 
located outside the scan range. Besides several case reports, 
little information is available on the diagnostic value of 
18F-FDG-PET/CT and MRI in paravertebral and psoas 
abscesses [6, 7, 20].
Specificity remains an issue when using 18F-FDG-PET/
CT, in particular because it can be very difficult to reli-
ably distinguish infection from malignancy. In our study, 
one 18F-FDG-PET/CT scored as false positive in a patient 
with a spinal metastasis. Nevertheless, nine of 50 patients 
with spondylodiscitis had a history of malignancy and 
18F-FDG-PET/CT correctly diagnosed spondylodiscitis 
in eight of these patients with high specificity (95 %) in 
this subgroup. 18F-FDG-PET/CT may become a promis-
ing alternative in patients in whom MRI is contraindi-
cated due to the presence of metallic implants in the spine 
Fig. 2  18F-FDG-PET/CT images before and after therapy in a 
35-year-old woman with Candidemia (Candida albicans). 18F-FDG-
PET/CT showed increased 18F-FDG-accumulation at the level L5–
S1 (a, c), spondylodiscitis was confirmed by spinal biopsy which 
also showed Candida albicans. The 18F-FDG-PET/CT was repeated 
after 5 months of therapy with fluconazole and showed only minimal 
18F-FDG-uptake (b, d) which was interpreted as reactive changes 
after treatment for spondylodiscitis
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or certain pacemakers. Even when spinal implants are 
MRI-compatible, they can give rise to artifact and limit 
diagnostic capability. De Winter et al. showed the value 
of 18F-FDG-PET in excluding spondylodiscitis in patients 
with metallic implants and after spinal surgery (sensitiv-
ity 100 %) [21]. Specificity was 65 % in patients with a 
metallic implant. In 18F-FDG-PET/CT, whole body imag-
ing provides the opportunity to identify septic foci else-
where, possibly even in identifying endocarditis (which 
appears relatively often simultaneously with spondylodis-
citis) [22].
There are some limitations to our study. First, inherent 
to the retrospective nature of this study, it might be sub-
jected to bias. In order to reduce bias, however, patients 
diagnosed with spondylodiscitis on only MRI or 18F-FDG-
PET/CT, and patients suspected of this diagnosis with more 
than a 14-day delay between both imaging modalities were 
not included. Furthermore, images were interpreted in the 
clinical setting by different physicians; no revision by a sin-
gle reader had been performed in order to reduce bias and 
to simulate the clinical setting, since revision could affect 
interpretation based on progressive insight during hospitali-
zation. This could be an explanation for the fact that diag-
nostic values of subsequent MRI imaging improved. This 
study was multi-center, which entails the use of different 
scanners, acquisition and reconstruction parameters. In 
our study, 13 of 68 MRI images were performed without 
intravenous injection of gadolinium. Nowadays, it is rec-
ommended to perform contrast-enhanced MRI in patients 
suspected of spondylodiscitis.
In all participating centers, 18F-FDG-PET/CT has 
become the diagnostic standard to evaluate (high risk) 
patients with a Gram-positive bacteraemia systemati-
cally regarding metastatic infections [8]. This explains the 
high number of patients with Gram-positive bacteraemia 
included in the study, which may also be the reason for the 
high percentage of patients in whom a causative organism 
was identified (94 %) as compared to other studies (40–
60 %) [1, 3, 23].
In patients with Gram-positive bacteraemia, cost-effec-
tiveness of routine 18F-FDG-PET/CT has already been 
shown [8]. Whether this also holds true for other patients 
suspected of spondylodiscitis should be the subject of 
future studies. In the Netherlands, mean costs for MRI 
of the spine and 18F-FDG-PET/CT are 325 euro and 900 
euro, respectively. Evaluation of the response to antibiotic 
treatment was outside the scope of our study, but is of high 
interest. Treatment effect is usually evaluated based on clin-
ical condition and CRP levels. MRI abnormalities may per-
sist despite clinical improvement and therefore cannot be 
used in early treatment evaluation [24]. Preliminary results 
have shown that 18F-FDG-PET/CT may be a promising 
modality for evaluation of treatment effect, which warrants 
further study [25]. Glaudemans et al. already addressed the 
possible advantages of the usage of simultaneous PET/MRI 
in suspected spondylodiscitis and in follow-up during treat-
ment [26]. In our opinion this might be an excellent com-
bination of the diagnostic value of 18F-FDG-PET for spon-
dylodiscitis and the epidural and spinal abscess detection 
of MRI.
Conclusion
18F-FDG-PET/CT shows superior diagnostic value in the 
early course of spondylodiscitis when compared to MRI. 
After 2 weeks of symptoms both modalities have simi-
lar yield. MRI showed highest sensitivity in diagnosing 
epidural and spinal abscesses while 18F-FDG-PET/CT 
was more sensitive in diagnosing paravertebral and psoas 
abscesses.
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